Glaucoma Clinical Trials

A listing of Glaucoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 127 clinical trials
MRCT Evaluating NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension (Denali)

-angle glaucoma. Subjects will be randomized in a 1:1 ratio to NCX 470 0.1% or to latanoprost 0.005% to be administered to both eyes once daily in the evening for up to 12 months.

intraocular pressure
glaucoma
ophthalmic solution
corrected visual acuity
hypertension
  • 1 views
  • 10 May, 2022
  • 1 location
Village-Integrated Eye Worker Trial II (VIEW II)

treatment. The leading causes of visual impairment are cataract and refractive error, followed by glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy (DR). Loss of vision from these

cataract
brimonidine tartrate ophthalmic solution
eye disease
eye disorder
intraocular pressure
  • 42 views
  • 10 Feb, 2022
  • 1 location
A Therapeutic Equivalence Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

This is a randomized, Investigator-masked, multi-center, parallel group, therapeutic equivalence study with clinical endpoint.

brinzolamide ophthalmic suspension
glaucoma
brinzolamide
hypertension
primary open angle glaucoma
  • 8 views
  • 09 Jul, 2022
  • 29 locations
Village-Integrated Eye Worker Trial II - Pilot (VIEW II Pilot)

treatment. The leading causes of visual impairment are cataract and refractive error, followed by glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy (DR). Loss of vision from these

cataract
brimonidine tartrate ophthalmic solution
eye disease
eye disorder
bilateral cataracts
  • 128 views
  • 04 Mar, 2022
  • 1 location
Manhattan Vision Screening and Follow-Up Study

The investigators are conducting a 5-year prospective, cluster-randomized controlled trial, funded by the Centers for Disease Control (CDC), which provides vision screenings to underserved, vulnerable New York City residents living in affordable housing buildings in Harlem and Washington Heights.

brimonidine tartrate ophthalmic solution
eye exam
Accepts healthy volunteers
  • 16 views
  • 27 Feb, 2022
Bimodal and Coaxial High Resolution Ophtalmic Imaging

The knowledge of the pathogenesis of retinal affections, a major cause of blindness, has greatly benefited from recent advances in retinal imaging. However, optical aberrations of the ocular media limit the resolution that can be achieved by current techniques. The use of an adaptive optics system improves the resolution of …

  • 0 views
  • 26 Jan, 2021
  • 1 location
Outcomes Mandate National Integration With Cannabis as Medicine (OMNI-Can)

This will be a multistate, multicenter clinical study to determine the efficacy and safety of medical cannabis for a wide variety of chronic medical conditions.

medical marijuana
brimonidine tartrate ophthalmic solution
Accepts healthy volunteers
covid-19
disease or disorder
  • 15111 views
  • 13 Jun, 2022
  • 16 locations
The Support, Educate, Empower (SEE) Program (SEE)

This study will test whether the Support, Educate, Empower (SEE) personalized Glaucoma Coaching Program improves eye drop medication adherence among glaucoma patients compared to enhanced

ocular hypotensive
hypotensive
hypertension
glaucoma
  • 0 views
  • 02 May, 2022
  • 1 location
Evaluation of Minimal Invasive Glaucoma Surgery

Glaucoma is a neurodegenerative disease with an accelerated and progressiv retinal ganglion cell loss and concomitant visual field defects. Glaucoma can be treated with eye drops, laser therapy

trabeculectomy
intraocular pressure
ganglion
brimonidine tartrate ophthalmic solution
glaucoma surgery
  • 0 views
  • 24 Mar, 2022
  • 1 location
GlaucoT Glaucoma Treatment Glasses in the Treatment of Primary Open-Angle Glaucoma (GlaucoT)

Glaucoma is a chronic and progressive optic neuropathy characterized by degeneration of ganglion cells and axons with loss of visual function. It is estimated that glaucoma, which is the

ganglion
neuropathy
optical coherence tomography
intraocular pressure
optic neuropathy
  • 0 views
  • 14 Apr, 2022